CalciMedica Inc.

CALC | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.82

-$0.04 (-2.15%)

Sep 22, 2026, 11:51 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-2.15%

(1D)

Rating

Updated: Sep 1, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $5.73M

1D Range

1.79 1.93

52W Range

1.79 36

Valuation (TTM)

PE -0.27

PB 1.06

EV/EBITDA 0.64

Valuation (NTM)

Forward PE N/A

Forward PEG -0.00

Price Target $266

Cash Flow

FCF Yield -326.5%

SBC Adj. FCF Yield -366.6%

SBC Impact -12.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 15.1% | 61.7%

FCF 3Y | 5Y 1.4% | 2.9%

Returns

ROA -108.9%

ROE 3398.4%

ROIC -122.6%

Financial Health

Net Cash

$18.62M

Current Ratio 5.58

Interest Coverage -15.16

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequa...

Sector Healthcare

Industry Biotechnology

Employees 15

IPO Date Jun 13, 2023

Website www.calcimedica.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$392

Upside

+21438.46%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞